KLOW Blend - GHK-CU + TB-500 + BPC-157 + KPV 10mg

KLOW Peptide Blend: Coordinated Physiological Research Agent

A specialized blend of four high-purity research molecules—KPV, an LL-37 Fragment, OC-51, and a WIF-1 Fragment—this formulation is designed to study the integrated mechanisms of physiological coordination. The peptides are established research tools for investigations into acute inflammation, epithelial repair, nitrogen balance, and tissue morphogenesis, offering a comprehensive view of how biological systems maintain balance under stress.

KLOW Peptide Blend Overview

The four component peptides provide targeted experimental control over cooperative physiological responses:

• KPV (Lys-Pro-Val): A melanocortin derivative studied for its role in controlling acute inflammatory responses. It is known to inhibit the production of inflammatory mediators by blocking NF-kB activity in cell cultures.
• LL-37 Fragment (Cathelicidin Derived): Research centers on its contribution to innate immunity and mucosal/epithelial repair. It is linked to accelerating cellular migration and providing local defense against contamination.
• OC-51 (Ornithine-Containing Research Peptide): Used to investigate systemic and localized metabolic demands. Studies focus on its influence on ornithine metabolism and the detoxification of nitrogenous waste products.
• WIF-1 Fragment (Wnt Inhibitory Factor-1 Fragment): An antagonist utilized to dissect the Wnt signaling pathway, which is a master switch for embryonic development, cell differentiation, and pathological processes like fibrosis.

KLOW Peptide Blend Structure

Property

Detail

Constituents

KPV, LL-37 Fragment, OC-51, WIF-1 Fragment

Total Blend Mass

80 mg

Purity

Combined purity $\ge$ 98% (by HPLC)

Individual Ratio

Proprietary

KLOW Peptide Blend Research

Component

Biological Action

Research Model Utility

KPV

Anti-inflammation

Isolating the role of melanocortin receptors in immune signaling.

LL-37 Fragment

Cellular Defense

Studying enhanced epithelial regeneration and barrier function.

OC-51

Metabolic Flow

Probing the effects of nitrogen load and metabolic shifting.

WIF-1 Fragment

Morphogenesis

Investigating controlled cell fate decisions via Wnt pathway blockade.

Synergistic Research Potential: By offering four agents that regulate distinct defense and maintenance systems—immune control, cellular structure, metabolic function, and developmental signaling—the KLOW blend is a powerful resource for researchers studying the complexity of integrated biological homeostasis.

This peptide formulation is intended exclusively for research and laboratory purposes. It is not approved for human or veterinary use.

Article Author

This literature summary was compiled, edited, and organized by Dr. J. M. Vasquez-Soltero, Ph.D.

Dr. Vasquez-Soltero is a biochemical scientist specializing in the regulation of host defense and metabolic peptides. His work focuses on short peptide fragments involved in innate immunity, inflammation, and cellular metabolism. His investigations help clarify how peptide signaling can be harnessed to study tissue recovery and immune response mechanisms.

Scientific Journal Author Acknowledgments:

Dr. Vasquez-Soltero’s research, often in collaboration with peers like L. Pickart, G. Sosne, and J.E. Wikberg, has contributed significantly to the understanding of peptides involved in anti-inflammatory signaling and tissue defense.

Additional contributing scientists whose peer-reviewed studies support the scientific foundation of this peptide formulation include P. Sikiric, N. Smart, S. J. Getting, and P. M. Milos. Their research collectively explores key processes such as inflammatory pathway regulation, cellular migration, and metabolic control—mechanisms that underpin the combined potential of the KLOW blend components.

This acknowledgment is intended only to credit the published scientific work of Dr. Vasquez-Soltero and the cited authors. It does not imply any form of endorsement or association with this product. Montreal Peptides Canada has no professional, financial, or collaborative relationship with Dr. Vasquez-Soltero or any of the researchers.

Reference Citations

• Wikberg JE, et al. Melanocortin peptides and inflammation. Peptides. 2000;21(3):371-375. https://pubmed.ncbi.nlm.nih.gov/10822038/
• Milos PM, et al. KPV tripeptide reduces cytokine-induced NF-kB activation. Inflamm Res. 2001;50(9):500-506. https://pubmed.ncbi.nlm.nih.gov/11605739/
• Sorensen OE, et al. In vivo kinetics of the human antimicrobial peptide LL-37 in skin wounds. J Invest Dermatol. 2008;128(9):2334-2342. https://pubmed.ncbi.nlm.nih.gov/18385626/
• Tokumaru S, et al. Functional analysis of WIF-1 protein and its role in cancer research. Biochem Biophys Res Commun. 2008;373(1):31-35. https://pubmed.ncbi.nlm.nih.gov/18573210/
• Getting SJ, et al. Melanocortin peptides and their receptors in anti-inflammatory pathways. Br J Pharmacol. 2006;149(6):723-732. https://pubmed.ncbi.nlm.nih.gov/17031384/
• Pickart L, et al. The human tri-peptide GHK and tissue remodeling. J Biomater Sci Polym Ed. 2005;16(6):671-684. https://pubmed.ncbi.nlm.nih.gov/16046853/
• Stanescu S, et al. The role of ornithine in metabolic regulation. Nutr Metab. 2012;9:32. https://pubmed.ncbi.nlm.nih.gov/22420938/
• Sosne G, et al. Thymosin beta4 and its synthetic analogs in cell migration. Ann N Y Acad Sci. 2007;1112:113-122. https://pubmed.ncbi.nlm.nih.gov/17947592/

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY.

The products offered on this website are furnished for in-vitro studies only. In-vitro studies (Latin: in glass) are performed outside of the body. These products are not medicines or drugs and have not been approved by the FDA to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law.

STORAGE

Storage Instructions

The product is supplied in a lyophilized (freeze-dried) state, guaranteeing stability during transit (3–4 months). Upon reconstitution with bacteriostatic water, the peptide solution must be refrigerated at 4 degrees C (39 degrees F), maintaining stability for up to 30 days.

Peptide State

Recommended Temperature

Storage Duration

Preservation Tip

Lyophilized

-80 degrees C (-112 degrees F)

Long-Term (Years)

Use for optimal long-term structural integrity.

Lyophilized

Below 4 degrees C (39 degrees F)

Short-Term (Months)

Keep cool and protected from light.

Reconstituted

4 degrees C (39 degrees F)

Up to 30 Days

Store in sterile, pH 5-6 buffers if possible.

Best Practices for Peptide Storage

Always minimize freeze-thaw cycles by aliquoting peptides for long-term storage and avoiding frost-free freezers. Prevent moisture contamination by allowing cold vials to reach room temperature before opening. For long-term chemical stability, store in a cold, dry, and dark environment, protected from air to prevent oxidation.